Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.
Decreased Frontal Lobe Gray Matter Perfusion in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis Detected by the Bookend Technique.
Motor impairments at presentation of clinically isolated syndrome suggestive of multiple sclerosis: Characterization of different disease subtypes.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
MS and NMO: Partners No More.
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes.
Physical Activity Behavior Change in Persons With Neurologic Disorders: Overview and Examples From Parkinson Disease and Multiple Sclerosis.
CD4 cell response to interval therapy with natalizumab.
Characterization of human platelet binding of recombinant T cell receptor ligand.
Information on natalizumab (marketed as Tysabri)
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide.
A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.
Association Between Multiple Sclerosis and Erectile Dysfunction: A Nationwide Case-Control Study.
Oligodendrocytes and the early multiple sclerosis lesion.
Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon.
Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.
The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.
Concurrent saturation transfer contrast in in vivo brain by a uniform magnetization transfer MRI.
Severe haematological complications during treatment with natalizumab.

Pages